Cargando…

Improvement in toxicity in high risk prostate cancer patients treated with image-guided intensity-modulated radiotherapy compared to 3D conformal radiotherapy without daily image guidance

BACKGROUND: Image-guided radiotherapy (IGRT) facilitates the delivery of a very precise radiation dose. In this study we compare the toxicity and biochemical progression-free survival between patients treated with daily image-guided intensity-modulated radiotherapy (IG-IMRT) and 3D conformal radioth...

Descripción completa

Detalles Bibliográficos
Autores principales: Sveistrup, Joen, af Rosenschöld, Per Munck, Deasy, Joseph O, Oh, Jung Hun, Pommer, Tobias, Petersen, Peter Meidahl, Engelholm, Svend Aage
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922544/
https://www.ncbi.nlm.nih.gov/pubmed/24495815
http://dx.doi.org/10.1186/1748-717X-9-44
_version_ 1782303465681190912
author Sveistrup, Joen
af Rosenschöld, Per Munck
Deasy, Joseph O
Oh, Jung Hun
Pommer, Tobias
Petersen, Peter Meidahl
Engelholm, Svend Aage
author_facet Sveistrup, Joen
af Rosenschöld, Per Munck
Deasy, Joseph O
Oh, Jung Hun
Pommer, Tobias
Petersen, Peter Meidahl
Engelholm, Svend Aage
author_sort Sveistrup, Joen
collection PubMed
description BACKGROUND: Image-guided radiotherapy (IGRT) facilitates the delivery of a very precise radiation dose. In this study we compare the toxicity and biochemical progression-free survival between patients treated with daily image-guided intensity-modulated radiotherapy (IG-IMRT) and 3D conformal radiotherapy (3DCRT) without daily image guidance for high risk prostate cancer (PCa). METHODS: A total of 503 high risk PCa patients treated with radiotherapy (RT) and endocrine treatment between 2000 and 2010 were retrospectively reviewed. 115 patients were treated with 3DCRT, and 388 patients were treated with IG-IMRT. 3DCRT patients were treated to 76 Gy and without daily image guidance and with 1–2 cm PTV margins. IG-IMRT patients were treated to 78 Gy based on daily image guidance of fiducial markers, and the PTV margins were 5–7 mm. Furthermore, the dose-volume constraints to both the rectum and bladder were changed with the introduction of IG-IMRT. RESULTS: The 2-year actuarial likelihood of developing grade > = 2 GI toxicity following RT was 57.3% in 3DCRT patients and 5.8% in IG-IMRT patients (p < 0.001). For GU toxicity the numbers were 41.8% and 29.7%, respectively (p = 0.011). On multivariate analysis, 3DCRT was associated with a significantly increased risk of developing grade > = 2 GI toxicity compared to IG-IMRT (p < 0.001, HR = 11.59 [CI: 6.67-20.14]). 3DCRT was also associated with an increased risk of developing GU toxicity compared to IG-IMRT. The 3-year actuarial biochemical progression-free survival probability was 86.0% for 3DCRT and 90.3% for IG-IMRT (p = 0.386). On multivariate analysis there was no difference in biochemical progression-free survival between 3DCRT and IG-IMRT. CONCLUSION: The difference in toxicity can be attributed to the combination of the IMRT technique with reduced dose to organs-at-risk, daily image guidance and margin reduction.
format Online
Article
Text
id pubmed-3922544
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39225442014-02-13 Improvement in toxicity in high risk prostate cancer patients treated with image-guided intensity-modulated radiotherapy compared to 3D conformal radiotherapy without daily image guidance Sveistrup, Joen af Rosenschöld, Per Munck Deasy, Joseph O Oh, Jung Hun Pommer, Tobias Petersen, Peter Meidahl Engelholm, Svend Aage Radiat Oncol Research BACKGROUND: Image-guided radiotherapy (IGRT) facilitates the delivery of a very precise radiation dose. In this study we compare the toxicity and biochemical progression-free survival between patients treated with daily image-guided intensity-modulated radiotherapy (IG-IMRT) and 3D conformal radiotherapy (3DCRT) without daily image guidance for high risk prostate cancer (PCa). METHODS: A total of 503 high risk PCa patients treated with radiotherapy (RT) and endocrine treatment between 2000 and 2010 were retrospectively reviewed. 115 patients were treated with 3DCRT, and 388 patients were treated with IG-IMRT. 3DCRT patients were treated to 76 Gy and without daily image guidance and with 1–2 cm PTV margins. IG-IMRT patients were treated to 78 Gy based on daily image guidance of fiducial markers, and the PTV margins were 5–7 mm. Furthermore, the dose-volume constraints to both the rectum and bladder were changed with the introduction of IG-IMRT. RESULTS: The 2-year actuarial likelihood of developing grade > = 2 GI toxicity following RT was 57.3% in 3DCRT patients and 5.8% in IG-IMRT patients (p < 0.001). For GU toxicity the numbers were 41.8% and 29.7%, respectively (p = 0.011). On multivariate analysis, 3DCRT was associated with a significantly increased risk of developing grade > = 2 GI toxicity compared to IG-IMRT (p < 0.001, HR = 11.59 [CI: 6.67-20.14]). 3DCRT was also associated with an increased risk of developing GU toxicity compared to IG-IMRT. The 3-year actuarial biochemical progression-free survival probability was 86.0% for 3DCRT and 90.3% for IG-IMRT (p = 0.386). On multivariate analysis there was no difference in biochemical progression-free survival between 3DCRT and IG-IMRT. CONCLUSION: The difference in toxicity can be attributed to the combination of the IMRT technique with reduced dose to organs-at-risk, daily image guidance and margin reduction. BioMed Central 2014-02-04 /pmc/articles/PMC3922544/ /pubmed/24495815 http://dx.doi.org/10.1186/1748-717X-9-44 Text en Copyright © 2014 Sveistrup et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Sveistrup, Joen
af Rosenschöld, Per Munck
Deasy, Joseph O
Oh, Jung Hun
Pommer, Tobias
Petersen, Peter Meidahl
Engelholm, Svend Aage
Improvement in toxicity in high risk prostate cancer patients treated with image-guided intensity-modulated radiotherapy compared to 3D conformal radiotherapy without daily image guidance
title Improvement in toxicity in high risk prostate cancer patients treated with image-guided intensity-modulated radiotherapy compared to 3D conformal radiotherapy without daily image guidance
title_full Improvement in toxicity in high risk prostate cancer patients treated with image-guided intensity-modulated radiotherapy compared to 3D conformal radiotherapy without daily image guidance
title_fullStr Improvement in toxicity in high risk prostate cancer patients treated with image-guided intensity-modulated radiotherapy compared to 3D conformal radiotherapy without daily image guidance
title_full_unstemmed Improvement in toxicity in high risk prostate cancer patients treated with image-guided intensity-modulated radiotherapy compared to 3D conformal radiotherapy without daily image guidance
title_short Improvement in toxicity in high risk prostate cancer patients treated with image-guided intensity-modulated radiotherapy compared to 3D conformal radiotherapy without daily image guidance
title_sort improvement in toxicity in high risk prostate cancer patients treated with image-guided intensity-modulated radiotherapy compared to 3d conformal radiotherapy without daily image guidance
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922544/
https://www.ncbi.nlm.nih.gov/pubmed/24495815
http://dx.doi.org/10.1186/1748-717X-9-44
work_keys_str_mv AT sveistrupjoen improvementintoxicityinhighriskprostatecancerpatientstreatedwithimageguidedintensitymodulatedradiotherapycomparedto3dconformalradiotherapywithoutdailyimageguidance
AT afrosenscholdpermunck improvementintoxicityinhighriskprostatecancerpatientstreatedwithimageguidedintensitymodulatedradiotherapycomparedto3dconformalradiotherapywithoutdailyimageguidance
AT deasyjosepho improvementintoxicityinhighriskprostatecancerpatientstreatedwithimageguidedintensitymodulatedradiotherapycomparedto3dconformalradiotherapywithoutdailyimageguidance
AT ohjunghun improvementintoxicityinhighriskprostatecancerpatientstreatedwithimageguidedintensitymodulatedradiotherapycomparedto3dconformalradiotherapywithoutdailyimageguidance
AT pommertobias improvementintoxicityinhighriskprostatecancerpatientstreatedwithimageguidedintensitymodulatedradiotherapycomparedto3dconformalradiotherapywithoutdailyimageguidance
AT petersenpetermeidahl improvementintoxicityinhighriskprostatecancerpatientstreatedwithimageguidedintensitymodulatedradiotherapycomparedto3dconformalradiotherapywithoutdailyimageguidance
AT engelholmsvendaage improvementintoxicityinhighriskprostatecancerpatientstreatedwithimageguidedintensitymodulatedradiotherapycomparedto3dconformalradiotherapywithoutdailyimageguidance